In This Issue
- Don’t Miss the Excitement of the 2012 Life Sciences Summit
- Georgia Bio Joins AdvaMed’s SMTA to Better Serve Med Device Companies
- Schools Need Industry Collaborations to Support Biotech Education
- Industry – University Partnerships Help Spur Economic Development
- Washington Update – August 2012
Welcome to the Life Sciences Voice
The new Georgia Bio Newsletter
Welcome to our new electronic newsletter, The Life Sciences Voice! We are very excited to bring you a more user friendly format designed to help inform our members about what is happening in Georgia’s Life Science community, as well as what Georgia Bio is doing to add value to each and every member.
Georgia Education Survey
Submit Your Feedback by Aug. 24
The Georgia Department of Education wants industry input on new curricula being designed around 17 separate "career clusters”. Here is a link to a short survey: https://www.survey.uga.edu/ctae/.
Services to help you grow. Resources to help you thrive.
Your job is to manage your company’s resources wisely, and our job is to help your organization save money. Georgia Bio has partnered with the Biotechnology Industry Organization (BIO), the international association for the biotech industry, to offer GaBio members discounts and other benefits on products and services from industry-leading suppliers through BIO’s cost-savings program, BIO Business Solutions. This partnership provides GaBio members excellent discounts and special benefits on such products and services as laboratory products and equipment, clinical trials liability and other lines of commercial insurance policies, news distribution services, office supplies, computer and technology products and more.
GaBio's Purchasing Program will save your organization time and money
Many members have saved over the years, here are just some who take advantage and save! Learn more at www3.bio.org/bbs/georgia/.
- Abeome Corporation
- Aderans Research
- Alimera Sciences, Inc.
- C.R. Bard
- Geovax Labs, Inc.
- SJ Pharmaceuticals, LLC
Early Registration & Abstract Deadline
Policy. Partnership. Action.
Georgia Bio is the state’s leading advocate for advancing the life sciences. Through advocacy work in Georgia and Washington D.C., Georgia Bio conducts programs, provides leadership and advocates for life science companies and university research essential to improving the health and economy of Georgia.
Sustaining the lobbying efforts of Georgia Bio requirse additional resources. Make a donation to help us educate our elected officials about the significance of the life sciences industry. Contact email@example.com for details.
Don’t Miss the Excitement of the 2012 Life Sciences Summit
Early Registration Discounts End Aug. 31 – Register Now
Georgia Bio members who register for the 2012 Georgia Life Sciences Summit before August 31 receive a $100 discount. You won’t want to miss this year’s Summit, the Southeast’s premier business and networking event for the life sciences industry.
The 11th annual Summit, Oct. 3, 2012, in Atlanta, will feature two global industry leaders as keynote speakers. Johnson & Johnson CEO Alex Gorsky will deliver the luncheon keynote and Baxter International’s Julie Kim, Global Franchise Head of Biotherapeutics, will speak in the morning session.
The Summit, held at the Georgia International Convention Center, also will include 12-panel sessions in which 50 expert speakers from industry, academia and government will share their insights on major trends and issues related to scientific research, product development, financing, business development and public policy.
The Summit theme is Innovation for Global Health. The conference is the one time each year Georgia’s companies and universities have the opportunity to showcase the enormous scope of their global leadership in bioscience innovation. About 1,000 professionals from across Georgia, the Southeast and the nation are expected to participate in this year’s event, which also serves as the only life sciences exposition in Georgia with an exhibit hall featuring the latest research, technology, products and services. Keep Reading
Georgia Bio Joins AdvaMed’s SMTA to Better Serve Med Device Companies
Georgia Bio has joined the Advanced Medical Technology Association’s (AdvaMed) State Medical Technology Alliance (SMTA) to enhance representation of Georgia’s medical device companies, particularly on issues related to government regulation and economic development.
The SMTA is a consortium 39 trade associations in 29 states that represent medical device manufacturers within their memberships. The Alliance’s mission is to collectively support the medical technology industry by fostering a collaborative environment through sharing of information, best practices and advocacy on public policy opportunities and issues.
"The medical device industry in Georgia is vital to both our local economy and to the need for innovation to improve health care globally,” said William Hawkins, President and CEO of Norcross-based Immucor and member of AdvaMedDX Board of Directors. "Georgia Bio’s partnership with AdvaMed is an important step in the right direction to ensure a unified voice with legislators at the local, state and federal levels. I am proud to support the collaborative efforts of Georgia Bio and AdvaMed and look forward to their ongoing support of medical innovation and job creation.”
As the industry addresses significant policy challenges, AdvaMed’s interactions and partnership with the state-based associations, such as Georgia Bio, has become increasingly important, especially for federal issues such as MDUFA implementation and the repeal of the medical device tax.
For more information on Georgia Bio’s partnership with AdvaMed’s SMTA, contact Georgia Bio President Charles Craig (firstname.lastname@example.org).
Schools Need Industry Collaborations to Support Biotech Education
Learn How You Can Get Involved
The goal of Georgia Bio’s Education and Workforce Development is to work with Educators and Industry to strengthen life sciences in Georgia. Through previous grants, Georgia Bio was able to support development of biotech courses now taught in 23 high schools across the state.
These programs have enabled biotech teachers to provide students with new opportunities such as laboratory experiences with PCR and gel electrophoresis, which are not found in the regular science curriculum.
Teachers have been at the forefront of biotechnology in high schools. In order to ensure that biotech programs in Georgia high schools are sustainable, teachers have expressed the following needs: interest in an equipment depot; increased professional development opportunities; and support for a visiting scientist program. With the necessary equipment, teachers are able to offer cutting edge laboratory experiences for their students. Teachers also are very interested in building relationships with industry. Having a visiting scientist come to these classrooms is crucial for a number of reasons, including giving students broader experience with possible career choices and examples of success in various sectors.
Georgia Bio wants to support establishing a culture of excellence in biotechnology education. In the process, it believes that biotechnology at the high school level has the potential to decrease the achievement gap, increase opportunity and access for urban and rural communities and educate the public on policy issues critical to the biotechnology industry.
Excellence does not sustain itself. Georgia Bio’s Education and Workforce Director Melissa Nikolic will be reaching out to Georgia Bio member companies to discuss with them the possibility of partnering with high schools in their areas to support biotech education. Please contact Melissa (Melissa.email@example.com) to arrange a meeting on how your company can participate.
Industry – University Partnerships Help Spur Economic Development
Georgia Bio’s Director of Industry Partnerships, Stacy Williams Shuker, Ph.D., has been working to connect business development professionals in global pharmaceutical and device companies with the tremendous assets in Georgia’s universities and companies. Fortunately the talent and resources in the state make Georgia an easy sell.
Georgia Bio is in the unique position to market all of Georgia to a company. The advantage it can provide is that it can reach out across all major research universities, as well as the smaller institutions and companies. This platform allows busy business development and licensing executives to get on a plane and travel to Atlanta to see the very best talent in their areas of interest from across the state in one room. While this is not traditional economic development, this is a novel way to showcase the state’s expansive research resources and keep Georgia in the minds of the major players in the life sciences industry.
Dr. Shuker already has organized visits by two pharmaceutical companies and one medical device company whose representatives spent the day with researchers from the universities. Other companies are in the process of scheduling visits.
In June at the 2012 BIO International Convention in Boston, Dr. Shuker had the opportunity to meet almost 20 companies from across the world during the official partnering session. Many of the companies she met with were very interested in Georgia’s platform and several remarked that they had never heard of such a program by a state. These meetings have already led to three more potential visits.
If your company or university would like to take advantage of this service, please contact Dr. Shuker (firstname.lastname@example.org). Also, if there are large corporations that you would like to build relationships with, Dr. Shuker can assist with your efforts.
Washington Update – August 2012
Download a Complete Federal Report including Updates on Tax Policy & Healthcare
With less than 100 days until Election Day, Congress has adjourned for the August recess. Both the House and Senate will reconvene after the national party conventions, which will take place on the last week of August (Republicans) and the first week of September (Democrats).
July saw a flurry of activity as Congress attempted to deal with some of the pressing issues before the month long break. Both the House and the Congressional Budget Office (CBO) addressed the Affordable Care Act (ACA) following the Supreme Court’s historic ruling in June. House and Senate leaders also made progress on a continuing resolution to fund the government and held largely political votes on the Bush tax cuts as the country edges closer to the "fiscal cliff.”
Read the complete Washington Update.
Georgia Bio Events
Morning Roundtable featuring Immucor's William Hawkins & CardioMEMS' Jay Yadav, M.D.
details coming soon
September 12, 2012
Managing your Clinical Supply Chain: Impact of Biosimilars
September 21, 2012
Small Group Dinner Series featuring Quintiles' JJ Spegele
Sepetember 24, 2012
Georgia Life Sciences Summit
October 3, 2012
Medical Devices Summit Midwest
September 6-7, 2012
2nd Annual Disruptive Innovations to Advance Clinical Trials
September 13-14, 2012
BioPharm America™ 2012—5th Annual International Partnering Conference
September 19–21, 2012
Stem Cells USA & Regenerative Medicine Congress
September 20-21, 2012
Global Clinical Trials: Preferred CRO Partnerships
October 1-2, 2012
October 1-3, 2012
Georgia Bio Member Code: SUPPAR235
The 6th Peptide Engineering Meeting
October 2-5, 2012
Georgia Tech Bio Industry Symposium
October 8-9, 2012
GaBio Member Discount Code $100 Off: GeorgiaBio
Business Development Outreach Corner
Seeking Companies With Microbial Air Monitoring Systems
Does your company have a microbial air monitoring system on your manufacoring line or in the laboratory? If so, Fuji Keizai Group a leading research and publishing company in Japan is seeking a 1 hour meeting on September 17 or 18.
Please contact Stacy Shuker if you are interested in this opportunity email@example.com.
Seeking Companies Interested in Selling in German Market
The Georgia Department of Economic Development recently welcomed a German mercantile agency for drug, pharmaceutical and medical products to Georgia seeking Georgia companies interested in selling their products in Germany. Handlesvertretung typically sells to doctors and medical specialists.
Handlesvertretung is seeking drug, pharmaceutical and medical products only. It's target audience include general practitioners, surgeons, dermatologists, internists, pediatricians, and orthopedist. Please note that your product must be licensed for the German market.
Questions/Interest: Bernhard Fitger (firstname.lastname@example.org) or Carmen Grohmann (email@example.com)
Did You Know...
Georgia Bio can help you recruit the talent needed to grow your organization?
1. Visit the online Career Center
2. Select Create an Employer Account
3. Post jobs today!
Your destination for exciting Life Science job opportunities is just a click away?
1. Visit the online Career Center
2. Select Search for Jobs
3. Post your resume today!
You can update your profile & view the members only directory at our members center?
1. Go to www.gabio.org and select Member Center, Update Profile from the top navigation panel
2. Sign in using your email address as the user name and password ('gabio' is a default password, or email firstname.lastname@example.org to request one)
3. Look for the View/Edit Profile link under your name on the page that opens
4. Here you can edit your profile, even load a picture
5. Scroll to the bottom left for the member directories
For the E-Chroncile Archives